TLR4 and graft versus host disease: In mouse models, infusion of anti-inflammatory macrophages (trained using low-level exposure to a DAMP (i.e., toll-like receptor 4) agonist) reduced GVHD, while pro-inflammatory macrophages (exposed to Bacillus Calmette–Guérin components) worsened GVHD [14].